XTX Topco Ltd Makes New $251,000 Investment in Nutex Health Inc. (NASDAQ:NUTX)

XTX Topco Ltd acquired a new stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 7,905 shares of the company's stock, valued at approximately $251,000. XTX Topco Ltd owned approximately 0.15% of Nutex Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Drive Wealth Management LLC acquired a new position in Nutex Health during the fourth quarter valued at approximately $1,122,000. Legato Capital Management LLC raised its stake in shares of Nutex Health by 26.8% during the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock worth $1,004,000 after purchasing an additional 6,697 shares in the last quarter. Russell Investments Group Ltd. acquired a new stake in shares of Nutex Health in the 4th quarter valued at approximately $672,000. Baader Bank Aktiengesellschaft bought a new position in shares of Nutex Health in the fourth quarter valued at $206,000. Finally, American Century Companies Inc. acquired a new position in Nutex Health during the fourth quarter worth $1,362,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates purchased 1,000 shares of the company's stock in a transaction dated Tuesday, April 8th. The stock was bought at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the transaction, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. This represents a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Insiders own 38.52% of the company's stock.

Nutex Health Stock Performance

Shares of NUTX stock traded down $14.24 during midday trading on Tuesday, hitting $104.81. 146,383 shares of the company were exchanged, compared to its average volume of 58,210. The firm has a market capitalization of $579.39 million, a P/E ratio of -11.17 and a beta of 0.27. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. Nutex Health Inc. has a 52 week low of $4.16 and a 52 week high of $152.51. The firm's 50 day moving average price is $79.65 and its two-hundred day moving average price is $51.17.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its earnings results on Monday, March 31st. The company reported $11.12 EPS for the quarter, beating the consensus estimate of ($0.09) by $11.21. The company had revenue of $81.30 million for the quarter, compared to the consensus estimate of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Wall Street Analyst Weigh In

Separately, Maxim Group upped their price objective on Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.